Filtered By:
Source: BioScience Trends
Condition: Atrial Fibrillation
Management: Hospitals
This page shows you your search results in order of relevance.
Order by Relevance | Date
Total 16 results found since Jan 2013.
Contemporary oral anticoagulant therapy of patients with atrial fibrillation in China: Status, obstacles, and strategies for improvement
Biosci Trends. 2022 Oct 30. doi: 10.5582/bst.2022.01278. Online ahead of print.ABSTRACTAtrial fibrillation (AF) and subsequent stroke and death have become major public health problems in China. Oral anticoagulant (OAC) forms the backbone of prevention of AF-related stroke. However, the quality of OAC use in AF patients in China is not clear. The focus of this narrative review is to summarize the current status of OAC therapy in China and compare it with the studies conducted internationally. In general, most data of OAC use in China were reported around 10-50%, with an increasing proportion of high-risk patients receiving...
Source: BioScience Trends - October 30, 2022 Category: Biomedical Science Authors: Luxiang Shang Yujiao Zhang Yang Zhao Baopeng Tang Yinglong Hou Source Type: research
